Navigation Links
Biorem Reports 2014 Second Quarter Results
Date:8/22/2014

quarter of 2013. Year to date revenues have declined 52% to $4,433,000 compared to $9,195,000 in the same period in the prior year.  

Gross profit for the quarter was 2.2% of revenue compared to 16.7% for the quarter ended March 31, 2014 and 26.9% for the quarter ended June 30, 2013. Gross profit for the quarter was negatively impacted during the quarter by the one-time provision for loss that was recorded against a project that requires remedial work. In the absence of this provision for loss, gross profit for the quarter would have been $656,000 or 23.7 % of revenue which is consistent with the gross profit percentage achieved in previous quarters.

For the six month period gross profit decreased by $2,200,000, an 85% decrease from the gross profit of $2,585,000 recorded for the six months ended June 30, 2013.

Operating expenses in the quarter of $748,000 were 31% lower than the $1,088,000 of expenses recorded in the same period in the previous year. For the six months ended June 30, 2014 operating expenses were $1,482,000, a 29% decrease over operating expenses of $2,073,000 in the comparable period in 2013.
The decrease in operating expenses were largely the result of  lower sales commissions earned on the lower revenue recorded,  and by lower general and administrative costs and lower expenditures on research and development resulting from cost reductions initiated by the Company.

Net loss for the quarter and six months ended were $835,000, and $1,366,000 respectively compared to earnings of $254,000 and $223,000 in 2013.  On a loss per share basis loss for the quarter was $0.06 per share and $0.11 per share for the six month period ended June 30, 2014.

"We had expected the quarter to be soft since orders had slowed in the latter half of 2013. However orders are picking up along with evidence that the overall market conditions have improved significantly as evidenced by the growth in our backlog," said '/>"/>

SOURCE Biorem Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. DryLet to Attend UpTech Upstream Oil and Gas Summit on October 6-8, 2013 in Alberta to Showcase MB Bioremediation
2. DryLet Technologies Announces Website Launch and New Logo Design for Patented MB Bioremediation
3. Altogen Labs Announces Patent Filing for Bioremediation Process and Oil Spill Cleanup Products
4. Diabetes Drugs Industry Growth Analysis in Global, China Regions Research Report Available at DeepResearchReports.com
5. Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com
6. Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com
7. Dyadic International Reports Q2 2014 Financial Results
8. Sinovac Reports Unaudited Second Quarter Financial Results
9. Pressure BioSciences, Inc. Reports Second Quarter 2014 Financial Results and Provides Business Update
10. RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2014
11. Synthetic Biologics Reports Second Quarter 2014 Financial Results and Operational Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ... million.  The orders are for odour control projects in ... and Asia . "Bidding activity in ... President and CEO. "After a high volume year for bidding in ... the New Year.  The recent orders reflect the organization,s renewed focus ...
(Date:3/3/2015)... Adaptive Biotechnologies announced today that Chad ... of Director as Chair of the Audit Committee. ... oversees all finance, treasury and accounting functions. Since joining ... treasury and accounting functions, and led the finance organization ... he was named Puget Sound Business Journal,s CFO of ...
(Date:3/3/2015)... , March 3, 2015 Fried, Frank, Harris, ... I.D. Lewis has joined the Firm as a ... the New York office. Mr. ... matters, as well as other intellectual property and general ... Mr. Lewis represents both plaintiffs and defendants in a ...
(Date:3/3/2015)... N.J. , March 3, 2015  Thingee Corporation, ... will be delivering a presentation entitled, "Technology Adoption: Making ... Thriving through Innovations and Technology ,  in ... March 11 to 13, 2015. Audiences looking to learn ... effectively will want to be in the audience for ...
Breaking Biology Technology:Adaptive Biotechnologies adds Chad Cohen, Zillow Group CFO, to Board of Directors 2Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 2Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 3Thingee to present at 11th Annual Synergistix Users Conference 2
... The Board of,Directors, meeting today under the chairmanship of Albert Saporta, approved,STALLERGENES, half year consolidated financial statements:, (EUR millions) ... ... % ... change, Sales ...
... NLTX ), today announced that Peter Strumph, Chief ... the Biotech Industry,conference on Thursday, September 4, at 1:30 ... City. Mr. Strumph will provide a company,overview and update ... The presentation will be webcast live and can be ...
... Aug. 27 Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ... that Jerry McMahon, Ph.D., chairman and CEO,will participate ... he,will provide a corporate overview, including a discussion ... lead product candidate., -- The Thomas Weisel ...
Cached Biology Technology:Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit 2Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit 3Nile Therapeutics to Present at BioCentury's NewsMakers in the Biotech Industry Conference 2Poniard Pharmaceuticals Announces Upcoming Conference Participation 2
(Date:2/18/2015)... -- Cepheid (NASDAQ: CPHD ) today announced that its ... investors to participate via webcast. , Cowen and Company ... March 3, 2015 at 11.20 a.m. Eastern Time , ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... for these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62/113114 for DISTRIBUTED METHOD AND ... The patent further establishes NXT-ID,s position in the ... property portfolio the ability for multiple devices to collaborate ...
(Date:2/9/2015)...  Lintec of America recently announced an exclusive license ... macrostructures, including sheets, yarns and ribbons, developed at the ... the vast industrial resources of the global Lintec Group, ... of America is forming the Nano-Science and Technology Center ... on scaling up the manufacturing and commercialization of nano ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... of Rostock in Germany has developed a new way to ... using less energy than before. It,s expected that this breakthrough ... diverse range of applications; including transport and medical devices. ... open access journal Materials Today , reports on the ...
... research by UM bioclimatology Assistant Professor Ashley Ballantyne ... Arctic temperatures during the Pliocene era. His research ... the July issue of Nature Geoscience. The full ... Palaeoecology: An International Journal for the Geosciences ., ...
... sector, are accessible marine resources as they grow in ... every year and have become an important part of ... based on macroalgae for bioenergy, cosmetics and biomedicine. , ... led by the Spanish National Research Council (CSIC) that ...
Cached Biology News:Cool it, quick: Rapid cooling leads to stronger alloys 2Japan, China and South Korea account for 84 percent of the macroalgae patents 2
Dopamine D2 and D3 receptor, human and possibly mouse. AB1502 detects 40 ng of dopamine receptor peptide by ELISA. AB1502 is not neutralizing....
STX18 Immunogen: STX18 (NP_058626, 101 a.a. ~ 200 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Mouse monoclonal [CLB-SW16 (formerly 708)] to CD42d (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 2814 SwissProtID: P40197...
Request Info...
Biology Products: